Biocon — Fact Sheet (June 2022)

4 slides from Biocon's fact sheet, June 2022

Slide 1: Biocon Group Fact Sheet June 2022
BIOCON GROUP FACT SHEET June - 2022
Slide 2: Biocon Limited (Consolidated) Profit & Loss Statement Q1 FY23 vs Q1 FY22
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Particulars Q1'FY 23 Q1'FY 22 Variance % INCOME Generics 580 486 19% Biosimilars 977 758 29% Novel Biologics - 11 -100% Research services 645 595 8% Inter-segment (61) (89) -31% Revenue from operations # 2,140 1,761 22% Other income
Slide 3: Biocon Limited (Consolidated) Profit & Loss Statement Q1 FY23 vs Q4 FY22
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Particulars Q1' FY 23 Q4' FY 22 Variance % INCOME Generics 580 717 -19% Biosimilars 977 982 -1% Novel Biologics - 12 -100% Research services 645 758 -15% Inter-segment (61) (61) 0% Revenue from operations # 2,140 2,409 -11% Other inc
Slide 4: Biocon Limited (Consolidated) Balance Sheet
BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs Crores) Particulars June 30, 2022 March 31, 2022 ASSETS Non-current assets (a) Property, plant and equipment 5,807 5,677 (b) Capital work-in-progress 3,560 3,420 (c) Right-of-use assets 262 267 (d) Goodwill 26 26 (e) Other intangible assets 590 599 (f)